Home > Financial Ratios > BLISS GVS PHARMA

BLISS GVS PHARMA
EBIT Growth

    Back to All Ratios
BLISS GVS PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) 6.3197.66-47.11-18.43-26.72

What is the latest EBIT Growth ratio of BLISS GVS PHARMA ?

The latest EBIT Growth ratio of BLISS GVS PHARMA is 6.31 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar20246.31
Mar202397.66
Mar2022-47.11
Mar2021-18.43
Mar2020-26.72

How is EBIT Growth of BLISS GVS PHARMA Trending?

Years EBIT Growth % Change
Mar2024 6.31
-93.54
Mar2023 97.66
Positive
Mar2022 -47.11
Negative
Mar2021 -18.43
Negative
Mar2020 -26.72 -

Other Financial Ratios of BLISS GVS PHARMA


Compare EBIT Growth ratio of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹1,181.0 Cr -4.5% -6.6% -1.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,648.0 Cr -4.9% 2.1% 15.5% Stock Analytics
DIVIS LABORATORIES ₹159,310.0 Cr -2.2% 9.3% 50.5% Stock Analytics
CIPLA ₹119,410.0 Cr -4.2% 4.5% 4.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,189.0 Cr -4.4% -4.5% 17.2% Stock Analytics
DR REDDYS LABORATORIES ₹96,496.4 Cr -1.4% 4.2% -8.8% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

-4.5%

-6.6%

-1.5%

SENSEX

-1.3%

4.1%

7.6%


You may also like the below Video Courses